Thank you for your contribution!

Dear colleagues, friends and all who visited the website of UCARE2021 in Hiroshima, "A new era for urticaria - Advances in its classification and breakthroughs in its treatment".

I am pleased to tell you that the conference was completed as scheduled from 9 to 11 December 2021 in a hybrid format based in Hiroshima being connected to as many as 520 attendees in 45 countries. On the first day, we overviewed the progress of urticaria research and treatments in the last four decades, followed by reports from ongoing 9 projects and 25 new centers of UCARE accredited in the last two years.
The second day program was rich, containing 4 sessions about the pathogenesis and treatments of urticaria, angioedema, and pediatric urticaria, as well as oral and poster presentations, a sponsored luncheon seminar, and streamlined sponsored symposia.
On the last day, in addition to lectures about urticaria related syndromes and another sponsored luncheon seminar, interesting case studies of urticaria, and workshops of patient-reported outcomes and diagnostic procedures were undertaken.
Despite large differences in time and distances on the globe, the conference was extremely enthusiastic and interactive throughout the program, making a lot of discussion, awareness, and new relationships between the UCARE members.
I sincerely appreciate all attendees, committee members and coordinating office contributing to this wonderful conference.
I am looking forward to seeing you again in person, and wish you enjoy the holiday season and have a very happy new year.

All the best,
Michihiro Hide, MD, PhD

News

2022/2/1

The virtual conference website is now closed. Thank you all for participating in UCARE 2021.

2021/9/1

Abstract submission has been closed.

2021/8/23

Registration is opened.

2021/06/11

The GA²LEN UCARE Conference 2021 Website is now online.
Please come back often and use this website to register and submit your abstracts.